CMAC 2001; 3(4) | CMAC

CMAC 2001; 3(4)

Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(4):290-300
PDF

Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(4):301-315
PDF

Acute glomerulonephritis is a severe kidney disease that develops as a result of streptococcal skin and upper respiratory infections …

Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(4):316-323
PDF

The widespread of multy-resistant Gram-positive pathogens, especially methicillin-resistant staphylococci made us to reconsider our …
Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(4):324-338
PDF

The combination of ceftazidime with an aminoglycoside is a commonly used standard for empiric therapy of febrile neutropenia. A lot of …
Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(4):339-347
PDF

The approach to administration of antimicrobials is often based on the results of microbiological studies that include microorganism …
Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(4):348-354
PDF

According to the guidelines of American Thoracic Society, 2001.
Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(4):355-370
PDF

Translated and reprinted with permission from «International Journal of Antimicrobial Agents» 2001; 17:279-82.

Urinary …
Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(4):371-375
PDF